Cargando…

Association of serum albumin level with incidence and mortality of overt hepatic encephalopathy in cirrhosis during hospitalization

BACKGROUND: Hepatic encephalopathy (HE) is a serious complication of cirrhosis. Decreased serum albumin (ALB) level may facilitate the development of HE and accelerate the death of cirrhotic patients with HE. Recent evidence also suggests that human albumin infusion may reduce the incidence of HE an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Zhaohui, Guo, Xiaozhong, Tacke, Frank, Li, Yingying, Li, Hongyu, Qi, Xingshun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783662/ https://www.ncbi.nlm.nih.gov/pubmed/31636711 http://dx.doi.org/10.1177/1756284819881302

Ejemplares similares

Albumin infusion may decrease the incidence and severity of overt hepatic encephalopathy in liver cirrhosis
por: Bai, Zhaohui, et al.
Publicado: (2019)

Use of Human Albumin Administration for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis: A Systematic Review and Meta-Analysis
por: Bai, Zhaohui, et al.
Publicado: (2022)

Prediction and prevention of the first episode of overt hepatic encephalopathy in patients with cirrhosis
por: Gairing, Simon J., et al.
Publicado: (2023)

Overt Hepatic Encephalopathy Experienced by Individuals With Cirrhosis: A Qualitative Interview Study
por: Ladegaard Grønkjær, Lea, et al.
Publicado: (2018)

The Role of Presepsin in Diagnosing Infections in Patients with Liver Cirrhosis and Overt Hepatic Encephalopathy
por: Igna, Razvan, et al.
Publicado: (2022)

Human albumin infusion strategy in liver cirrhosis: liberal or restrictive?
por: Bai, Zhaohui, et al.
Publicado: (2021)

The Efficacy of Levocarnitine Treatment in Relieving Fatigue in Patients with Cirrhosis but without Overt Hepatic Encephalopathy
por: Abe, Kazumichi, et al.
Publicado: (2021)

Anomalous Gray Matter Structural Networks in Patients with Hepatitis B Virus-Related Cirrhosis without Overt Hepatic Encephalopathy
por: Lv, Xiao-Fei, et al.
Publicado: (2015)

Cortical signature of patients with HBV-related cirrhosis without overt hepatic encephalopathy: a morphometric analysis
por: Wu, Xiu, et al.
Publicado: (2015)

Abnormal corpus callosum induced by overt hepatic encephalopathy impairs interhemispheric functional coordination in cirrhosis patients
por: Kuang, Yangying, et al.
Publicado: (2021)

Effect of Admission Time on the Outcomes of Liver Cirrhosis with Acute Upper Gastrointestinal Bleeding: Regular Hours versus Off-Hours Admission
por: Li, Yingying, et al.
Publicado: (2018)

Prediction of overt hepatic encephalopathy by the continuous reaction time method and the portosystemic encephalopathy syndrome test in clinically mentally unimpaired patients with cirrhosis
por: Wernberg, Charlotte W., et al.
Publicado: (2019)

No Benefit of Hemostatic Drugs on Acute Upper Gastrointestinal Bleeding in Cirrhosis
por: An, Yang, et al.
Publicado: (2020)

Usefulness of the Stroop Test in Diagnosing Minimal Hepatic Encephalopathy and Predicting Overt Hepatic Encephalopathy
por: Hanai, Tatsunori, et al.
Publicado: (2021)

Primary Prophylaxis of Overt Hepatic Encephalopathy: Is It Time to Consider It?
por: Faccioli, Jessica, et al.
Publicado: (2023)

The incidence and outcome of postoperative hepatic encephalopathy in patients with cirrhosis
por: Saleh, Zachary M., et al.
Publicado: (2021)

Predicting overt hepatic encephalopathy after TIPS: Value of three minimal hepatic encephalopathy tests
por: Ehrenbauer, Alena F., et al.
Publicado: (2023)

Urinary metabolic profiling by (1)H NMR spectroscopy in patients with cirrhosis may discriminate overt but not covert hepatic encephalopathy
por: McPhail, Mark J. W., et al.
Publicado: (2016)

Impaired brain glucose metabolism in cirrhosis without overt hepatic encephalopathy: a retrospective (18)F-FDG PET/CT study
por: Zhang, Weishan, et al.
Publicado: (2019)

Role of D-dimer in the Development of Portal Vein Thrombosis in Liver Cirrhosis: A Meta-analysis
por: Dai, Junna, et al.
Publicado: (2015)

Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs
por: Roggeri, Daniela Paola, et al.
Publicado: (2015)

Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis
por: Bai, Zhaohui, et al.
Publicado: (2022)

Quantification of ascites based on abdomino-pelvic computed tomography scans for predicting the in-hospital mortality of liver cirrhosis
por: Wang, Ran, et al.
Publicado: (2017)

Beneficial effects of L-ornithine L-aspartate for prevention of overt hepatic encephalopathy in patients with cirrhosis: a systematic review with meta-analysis
por: Butterworth, Roger F.
Publicado: (2019)

Contrast-Enhanced CT May Be a Diagnostic Alternative for Gastroesophageal Varices in Cirrhosis with and without Previous Endoscopic Variceal Therapy
por: Li, Qianqian, et al.
Publicado: (2019)

Hepatic Encephalopathy Is Not Always due to Liver Cirrhosis
por: Ecker, Miriam Eva, et al.
Publicado: (2022)

Animal Naming Test – a simple and accurate test for diagnosis of minimal hepatic encephalopathy and prediction of overt hepatic encephalopathy
por: Agarwal, Ankit, et al.
Publicado: (2020)

Serum S100B Levels in Patients with Liver Cirrhosis and Hepatic Encephalopathy
por: Kim, Mo-Jong, et al.
Publicado: (2023)

Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt
por: Yin, Liang, et al.
Publicado: (2023)

Serum Liver Fibrosis Markers for Predicting the Presence of Gastroesophageal Varices in Liver Cirrhosis: A Retrospective Cross-Sectional Study
por: Qi, Xingshun, et al.
Publicado: (2015)

Association of coagulopathy with the risk of bleeding after invasive procedures in liver cirrhosis
por: Li, Jing, et al.
Publicado: (2018)

Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin
por: Neff, Guy, et al.
Publicado: (2018)

Neuroprotective Effect of Nortriptyline in Overt Hepatic Encephalopathy Through Attenuation of Mitochondrial Dysfunction
por: Jeong, Ji Heun, et al.
Publicado: (2018)

Prediction of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt treatment: a cohort study
por: Yang, Yang, et al.
Publicado: (2021)

Knowledge about non-invasive diagnostic tests for varices in liver cirrhosis: A questionnaire survey to the Gastroenterology Branch of the Liaoning Medical Association, China
por: Qi, Xingshun, et al.
Publicado: (2016)

Use of albumin infusion for cirrhosis-related complications: An international position statement
por: Bai, Zhaohui, et al.
Publicado: (2023)

Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology
por: Butterworth, Roger F.
Publicado: (2019)

Hepatic encephalopathy due to cardiac cirrhosis
por: Ono, Ryohei, et al.
Publicado: (2023)

Impact of spider nevus and subcutaneous collateral vessel of chest/abdominal wall on outcomes of liver cirrhosis
por: Li, Hongyu, et al.
Publicado: (2018)

Risk Factors for Esophageal Collateral Veins in Cirrhosis with and without Previous Endoscopic Esophageal Variceal Therapy
por: Li, Qianqian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n11utg8ij479u78rqbhdfvuldi